Investment Thesis
ALT5 Sigma exhibits severe fundamental deterioration with negative operating income of -$20.3M despite $19.5M in revenue, indicating structural unprofitability in core operations. The anomalous 190% net margin and $37M net income appear driven by non-operating gains rather than sustainable business performance. Deteriorating cash flow (-$15.5M operating), inadequate liquidity (0.79x current ratio), and complete absence of insider buying signal management lacks confidence in company viability.
ALTS Strengths
- Strong balance sheet with $1.6B in total assets
- Low debt burden with minimal long-term debt ($6.2M) and 0.00x debt/equity ratio
- Gross margin of 41% indicates viable unit economics before operating expenses
ALTS Risks
- Negative operating income of -$20.3M demonstrates core business is unprofitable and burning cash
- Operating cash flow of -$15.5M with negative FCF margin of -79.5% indicates unsustainable operations
- Current ratio of 0.79x below 1.0x threshold indicates liquidity stress and working capital deficit
- Net income appears artificially inflated through non-operating gains, masking operational distress
- Operating margin of -104.1% shows expenses exceed revenue by significant margin
- Zero insider Form 4 filings suggest lack of management conviction in company direction
Key Metrics to Watch
- Operating cash flow trend and path to positive cash generation
- Operating margin improvement and cost structure reduction
- Current ratio and working capital position to assess liquidity adequacy
- Breakdown of net income composition between operating and non-operating gains
- Revenue trends and ability to improve top-line growth
ALTS Financial Metrics
ALTS Profitability Ratios
ALTS Balance Sheet & Liquidity
ALTS 5-Year Financial Trend
5-Year Trend Summary: ALT5 Sigma Corp's revenue has declined by 66% over the 5-year period, indicating business contraction. The most recent EPS of $-1.95 indicates the company is currently unprofitable.
ALTS Growth Metrics (YoY)
ALTS Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $4.9M | -$822.0K | $-0.06 |
| Q2 2025 | $2.2M | $589.0K | $0.07 |
| Q1 2025 | N/A | -$2.1M | $-0.18 |
| Q3 2024 | N/A | -$214.0K | $-0.05 |
| Q2 2024 | N/A | $123.0K | $0.03 |
| Q1 2024 | N/A | -$2.1M | $-0.34 |
| Q3 2023 | N/A | -$214.0K | $-0.05 |
| Q2 2023 | N/A | $123.0K | $0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
ALTS Capital Allocation
ALTS SEC Filings
Access official SEC EDGAR filings for ALT5 Sigma Corp (CIK: 0000862861)